Metformin blocks the activation of mTORC1 and blocks the initiation of translation, especially the translation of c-myc, cyclin D1, and B-cell lymphoma-extra large (Bcl-xl), which are essential for cancer proliferation [20]. Here, BCL2L1 is linked to cancer.